Wegovy has been approved for use as a heart disease prevention medication, the FDA announced on Friday. The injectable semaglutide — originally approved for weight loss for certain patients — is now also indicated to reduce the risk of cardiovascular death, heart attack and stroke in adults who have cardiovascular disease and are either overweight or obese, the announcement stated.
" The FDA’s approval is a step in the right direction toward battling the "bias and stigma" around these medications, she said. "Significantly reducing the risk of cardiac disease in patients who are at a higher risk is incredibly important to both patients and clinicians," Pratt went on. "We hope that with this indication, these patients who unfortunately may not have had coverage for these medications before will soon find them covered.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »
Source: washingtonpost - 🏆 95. / 72 Read more »
Source: dcexaminer - 🏆 6. / 94 Read more »